{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T22:24:17Z","timestamp":1747175057214,"version":"3.40.5"},"reference-count":6,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"American Heart Association's"},{"name":"American Society of Nephrology's Carl W. Gottschalk Research Scholar"},{"name":"Hope Pharmaceuticals"},{"name":"Fresenius Renal Therapies"},{"name":"Epizon Pharma"},{"name":"Laboratoris Sanifit"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ackdjournal.org","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Chronic Kidney Disease"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1053\/j.ackd.2019.11.001","type":"journal-article","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T20:33:42Z","timestamp":1575923622000},"page":"407-408","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cardiovascular Calcifications Among Patients With Uremia: Answers to Hard Questions"],"prefix":"10.1053","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6750-0072","authenticated-orcid":false,"given":"Sagar U.","family":"Nigwekar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.ackd.2019.11.001_bib1","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(13)60598-X","article-title":"Atherosclerosis across 4000 years of human history: the Horus study of four ancient populations","volume":"381","author":"Thompson","year":"2013","journal-title":"Lancet"},{"issue":"6","key":"10.1053\/j.ackd.2019.11.001_bib2","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1053\/j.ajkd.2017.07.019","article-title":"KDOQI US commentary on\u00a0the 2017 KDIGO clinical practice guideline update for the diagnosis,\u00a0evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"70","author":"Isakova","year":"2017","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.ackd.2019.11.001_bib3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","article-title":"Executive summary of the 2017 KDIGO chronic kidney disease-mineral and bone disorder (CKD-MBD) guideline update: what's changed and why it matters","volume":"92","author":"Ketteler","year":"2017","journal-title":"Kidney Int"},{"issue":"7","key":"10.1053\/j.ackd.2019.11.001_bib4","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1093\/ndt\/gfr777","article-title":"Baseline characteristics of subjects enrolled in the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) trial","volume":"27","author":"Chertow","year":"2012","journal-title":"Nephrol Dial Transpl"},{"issue":"26","key":"10.1053\/j.ackd.2019.11.001_bib5","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMoa1205624","article-title":"Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis","volume":"367","author":"Investigators","year":"2012","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1053\/j.ackd.2019.11.001_bib6","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.stem.2018.05.009","article-title":"Modulating cell fate as a therapeutic strategy","volume":"23","author":"Lin","year":"2018","journal-title":"Cell Stem Cell"}],"container-title":["Advances in Chronic Kidney Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559519301983?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559519301983?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T14:16:51Z","timestamp":1575987411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1548559519301983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":6,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S1548559519301983"],"URL":"https:\/\/doi.org\/10.1053\/j.ackd.2019.11.001","relation":{},"ISSN":["1548-5595"],"issn-type":[{"type":"print","value":"1548-5595"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular Calcifications Among Patients With Uremia: Answers to Hard Questions","name":"articletitle","label":"Article Title"},{"value":"Advances in Chronic Kidney Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ackd.2019.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the National Kidney Foundation, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}